{
  "kind": "treatment",
  "slug": "butabarbital-butisol",
  "type": "sedative-hypnotic",
  "name": "Butabarbital (Butisol)",
  "summary": "A barbiturate sedative-hypnotic historically used for insomnia and preoperative sedation.",
  "description": "Butabarbital is an intermediate-acting barbiturate that depresses the central nervous system (CNS) by enhancing GABA-mediated chloride influx at the GABA-A receptor complex. It has been used for short-term management of insomnia, preoperative sedation, and anxiety relief. Due to its high risk of dependence, overdose, and availability of safer alternatives, its use has declined significantly in favor of benzodiazepines and non-benzodiazepine hypnotics.",
  "category": "medications/sedative-hypnotics",
  "tags": [
    "barbiturate",
    "sedative",
    "hypnotic",
    "insomnia",
    "preoperative"
  ],
  "metadata": {
    "drug_classes": [
      "Barbiturate",
      "Sedative-Hypnotic"
    ],
    "therapeutic_categories": [
      "Sleep Disorders",
      "Anxiety",
      "Preoperative Sedation"
    ],
    "mechanism_categories": [
      "GABA"
    ],
    "administration_routes": [
      "Oral"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": true,
    "generic_available": true,
    "brand_names": [
      "Butisol"
    ],
    "dea_schedule": "III",
    "fda_pregnancy_category": "D",
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Short-term"
    ],
    "specialty_areas": [
      "Psychiatry",
      "Anesthesiology",
      "Primary Care"
    ],
    "fda_approval_year": 1950
  },
  "clinical_metadata": {
    "primary_indications": [
      "Insomnia",
      "Other"
    ],
    "off_label_uses": [
      "Severe anxiety (short-term)",
      "Seizure control (rare)"
    ],
    "contraindications": [
      "Porphyria",
      "Severe respiratory depression",
      "History of substance use disorder"
    ],
    "monitoring_required": [
      "Signs of dependence",
      "Respiratory status",
      "CNS depression"
    ],
    "efficacy_rating": {
      "insomnia": 3,
      "anxiety": 2,
      "overall-tolerability": 2
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "butabarbital",
      "butisol",
      "barbiturate",
      "hypnotic",
      "sedative"
    ],
    "synonyms": [
      "butabarbital sodium"
    ],
    "common_misspellings": [
      "butabarbitol",
      "butabarbatal"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Short-term management of insomnia",
        "Preoperative sedation",
        "Short-term anxiety relief (off-label)"
      ]
    },
    {
      "type": "mechanism",
      "text": "Enhances the activity of GABA at the GABA-A receptor, increasing chloride ion influx into neurons, hyperpolarizing the cell membrane, and producing CNS depression."
    },
    {
      "type": "dosing",
      "adult": {
        "insomnia": "50–100 mg at bedtime",
        "preoperative-sedation": "100 mg given 60–90 minutes before surgery"
      },
      "geriatric": "Use lowest effective dose to minimize CNS depression risk",
      "hepatic_impairment": "Use with caution; may require dose adjustment",
      "renal_impairment": "Use with caution; accumulation possible"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 30 mg, 50 mg, 100 mg"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset: 30–60 minutes; Duration: 6–8 hours"
    },
    {
      "type": "adverse_effects",
      "common": [
        "drowsiness",
        "dizziness",
        "headache",
        "nausea"
      ],
      "less_common": [
        "confusion",
        "ataxia",
        "irritability"
      ],
      "serious": [
        "respiratory depression",
        "hypotension",
        "coma",
        "death in overdose"
      ]
    },
    {
      "type": "warnings",
      "black_box": null,
      "other": [
        "High potential for abuse, tolerance, and dependence",
        "Overdose can be fatal; narrow therapeutic index"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Alcohol",
          "risk": "Additive CNS depression",
          "action": "Avoid"
        },
        {
          "with": "Opioids",
          "risk": "Severe respiratory depression",
          "action": "Avoid or use with extreme caution"
        },
        {
          "with": "CNS depressants",
          "risk": "Additive sedation",
          "action": "Use lowest doses possible"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Level of sedation",
        "Signs of dependence or misuse",
        "Respiratory function"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Category D; risk of fetal harm and neonatal withdrawal",
      "lactation": "Excreted in breast milk; avoid use",
      "pediatrics": "Not recommended",
      "geriatrics": "Increased sensitivity; higher fall risk"
    },
    {
      "type": "tapering",
      "text": "Taper gradually to prevent withdrawal symptoms including seizures, agitation, and tremor."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Once common for insomnia; now rarely used due to safety concerns",
        "Consider only when safer alternatives fail"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "FDA Butabarbital Label",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "Barbiturates Clinical Overview",
          "url": "https://pubmed.ncbi.nlm.nih.gov/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Butabarbital (Butisol): Uses, Dosing, and Safety",
    "description": "Detailed monograph of butabarbital (Butisol), a barbiturate sedative-hypnotic used for insomnia and preoperative sedation."
  }
}
